Literature DB >> 3004227

Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.

S A Huber, P A Lodge.   

Abstract

DBA/2 and Balb/c mice, both H-2d, develop myocardial inflammation and necrosis when infected with a heart-adapted strain of coxsackievirus Group B, Type 3. Similar inoculation of C57Bl/6 (H-2b) animals results in minimal myocarditis despite equivalent heart virus titers in the three stains. Thus, the host's genetic constitution influences the pathogenesis of the infection. Anti-mouse thymocyte serum and monoclonal Iad antibody effectively prevent myocarditis induction in DBA/2 and Balb/c mice, which demonstrates the importance of the immune system in this disease. Cytolytic T lymphocytes lysing virus-infected and uninfected myocytes and heart-reactive autoantibodies occur in both myocarditis-susceptible strains. Cellular immunity causes the myocardial injury in Balb/c mice. Complement depletion of Balb/c mice using cobra venom factor fails to alter the disease. Similar treatment of DBA/2 animals abrogates inflammation and necrosis, which suggests that heart-reactive antibodies in this strain are primarily responsible for initiating myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004227      PMCID: PMC1888112     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.

Authors:  J F Woodruff; J J Woodruff
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

2.  Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

Review 3.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

4.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.

Authors:  B Maisch; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

5.  A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigens.

Authors:  S P Cobbold; H Waldmann
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Diagnosis and classification of myocarditis by endomyocardial biopsy.

Authors:  J J Fenoglio; P C Ursell; C F Kellogg; R E Drusin; M B Weiss
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

7.  Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai.

Authors:  M E Shapiro; S J Burakoff; B Benacerraf; R W Finberg
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

8.  Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice.

Authors:  S A Huber; L P Job
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

9.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis.

Authors:  L J Wolfgram; K W Beisel; N R Rose
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

10.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells.

Authors:  Y Matoba; B Sherry; B N Fields; T W Smith
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

4.  Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice.

Authors:  M T Barger; J E Craighead
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 5.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 6.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

Review 7.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Susceptibility to Coxsackievirus B3-induced chronic myocarditis maps near the murine Tcr alpha and Myhc alpha loci on chromosome 14.

Authors:  M D Traystman; L H Chow; B M McManus; A Herskowitz; M N Nesbitt; K W Beisel
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 9.  Diagnosing and treating active myocarditis.

Authors:  J B O'Connell; J W Mason
Journal:  West J Med       Date:  1989-04

10.  Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.

Authors:  H Zhang; G E Yousef; X Ouyang; L C Archard
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.